Urinary tract stone disease is a common clinical disorder that frequently leads to hospitalization. The objective of the proposed research is to gain new insights into the pathogenesis of urolithiasis through a comprehensive study of urinary protein inhibitors of calcium oxalate (CaOx) crystallization. The grant proposal has three Specific Aims.
Specific Aim #1 proposes to extend previous studies on uropontin (osteopontin found in the kidney) to evaluate the conformation of native and dephosphorylated uropontin and a series of synthetic unmodified and phosphorylated peptides which have aspartic acid-rich CaOx crystal binding domains within the protein sequence. The experimental plan proposes to use circular dichroism (CD), Fourier transform infrared spectroscopy (FTIR), and two-dimensional nuclear magnetic resonance spectroscopy (2D-NMR) for the structural studies to monitor differences in protein conformation and structure. It proposes to correlate these structural observations with parallel crystal growth inhibition studies.
Specific Aim #2 proposes a collaborative study to look for abnormalities in uropontin excretion in patients with accelerated CaOx nephrolithiasis. The co-investigator (Dr. Coe) has an extensive patient data base and can define those patients with at least 10 stone incidents, but a urinary CaOx supersaturation which does not account for the stone burden. The principal investigator will isolate proteins from patient urines, characterize the excretion patterns, and utilize the biophysical techniques described in Specific Aim #1 for structural characterization.
Specific Aim #3 proposes to isolate, purify and structurally study other urinary proteins that show crystal inhibitory properties. The applicant will use his set of immunologic reagents and monoclonal and polyclonal antibodies for the isolation and then use other molecular biological techniques to look for sequence homology with uropontin. Structural studies as described in Specific Aim #1 will potentially also be used.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK033501-11
Application #
2443966
Study Section
General Medicine B Study Section (GMB)
Project Start
1983-08-01
Project End
1999-06-30
Budget Start
1997-08-20
Budget End
1999-06-30
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Weaver, Matthew L; Qiu, S Roger; Hoyer, John R et al. (2009) Surface aggregation of urinary proteins and aspartic Acid-rich peptides on the faces of calcium oxalate monohydrate investigated by in situ force microscopy. Calcif Tissue Int 84:462-73
Wang, Lijun; Qiu, S Roger; Zachowicz, William et al. (2006) Modulation of calcium oxalate crystallization by linear aspartic acid-rich peptides. Langmuir 22:7279-85
Tang, R; Nancollas, G H; Giocondi, J L et al. (2006) Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation. Kidney Int 70:71-8
De Yoreo, James J; Qiu, S Roger; Hoyer, John R (2006) Molecular modulation of calcium oxalate crystallization. Am J Physiol Renal Physiol 291:F1123-31
Weaver, Matthew L; Qiu, S Roger; Hoyer, John R et al. (2006) Improved model for inhibition of pathological mineralization based on citrate-calcium oxalate monohydrate interaction. Chemphyschem 7:2081-4
Elhadj, S; De Yoreo, J J; Hoyer, J R et al. (2006) Role of molecular charge and hydrophilicity in regulating the kinetics of crystal growth. Proc Natl Acad Sci U S A 103:19237-42
Qiu, S Roger; Wierzbicki, Andrzej; Salter, E Alan et al. (2005) Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps. J Am Chem Soc 127:9036-44
Bleyer, Anthony J; Hart, Thomas C; Shihabi, Zak et al. (2004) Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein. Kidney Int 66:974-7
Qiu, S R; Wierzbicki, A; Orme, C A et al. (2004) Molecular modulation of calcium oxalate crystallization by osteopontin and citrate. Proc Natl Acad Sci U S A 101:1811-5
Hoyer, J R; Asplin, J R; Otvos, L (2001) Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals. Kidney Int 60:77-82

Showing the most recent 10 out of 26 publications